化合物Bemnifosbuvir hemisulfate T9331
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
100 mg | 2241337-84-6 | ¥10,900.00 | 询底价 |
1 mg | 2241337-84-6 | ¥892.00 | 询底价 |
10 mg | 2241337-84-6 | ¥3,230.00 | 询底价 |
5 mg | 2241337-84-6 | ¥1,990.00 | 询底价 |
50 mg | 2241337-84-6 | ¥8,250.00 | 询底价 |
25 mg | 2241337-84-6 | ¥5,720.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Bemnifosbuvir hemisulfate
描述: Bemnifosbuvir hemisulfate (AT-527) 是一种 HCV 病毒复制抑制剂。
体外活性: The potent in vitro activity of AT-511, the free base of bemnifosbuvir hemisulfate, against several coronaviruses, including SARS-CoV-2. In normal human airway epithelial cells, the concentration of AT-511 required to inhibit replication of SARS-CoV-2 by 90% (EC90) was 0.47?μM, very similar to its EC90 against human coronavirus (HCoV)-229E, HCoV-OC43, and SARS-CoV in Huh-7 cells[1].
体内活性: When given orally to rats and monkeys, bemnifosbuvir hemisulfate preferentially delivered high levels of AT-9010 in the liver in vivo.These favorable preclinical attributes support bemnifosbuvir hemisulfate may increase SVR rates[2].
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 170 mg/mL (269.60 mM)
关键字: Inhibitor | antiviral | phosphoramidate | HCV | nucleotide | Bemnifosbuvir | SARS-CoV | pangenotypic | Bemnifosbuvir hemisulfate | AT 527 | Bemnifosbuvir Hemisulfate | guanosine | SARS coronavirus | AT527 | Hepatitis C virus | inhibit
相关产品: Honokiol | PSI-352938 | Ladanein | GS-9256 | Maribavir | BMS-929075 | Saikosaponin B2 | PSI-6206 | Velpatasvir | BLT-1
相关库: Nucleotide Compound Library | Drug Repurposing Compound Library | Clinical Compound Library | Orally Active Compound Library | NO PAINS Compound Library | Covalent Inhibitor Library | Anti-Infection Compound Library
化合物Bemnifosbuvir hemisulfate T9331信息由TargetMol中国为您提供,如您想了解更多关于化合物Bemnifosbuvir hemisulfate T9331报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途